INNIO N.V. (Nasdaq: INIO) (“INNIO” or the “Company”) today announced that Fitch Ratings has upgraded the Company’s credit ratings, following a recent upgrade by Moody’s Ratings. INNIO also reaffirmed ...

US President Donald Trump arrives to participate in a ribbon cutting for the new helipad on the South Lawn of the White House ...

Aurora Solar today announced platform updates across the U.S., U.K., and Europe, reaching beyond solar + storage and into the electrified home.

OCP S.A. (“OCP” or the “Company”), a global leader in the fertilizer industry, will release its second quarter and first half 2026 results on Tuesday, September 29, 2026. The results will be available ...

Takeda(TSE:4502/NYSE:TAK)announced that new data from its oncology pipeline and portfolio will be presented at theEuropean Society for Medical Oncology (ESMO)Congress, taking place October 23-27, 2026 ...

US President Donald Trump is expected to claim he is winning both on the battlefield and as a peacemaker Tuesday in a speech to the United Nations overshadowed by ...

Quaise Energy, a leading developer of utility-scale superhot geothermal energy, today announced that it has been selected by the U.S. Department of Energy (DOE) for up to $25 million in funding under ...

Tunisia's summer this year was its hottest on record, the country's weather authority said Tuesday, following multiple heatwaves, ...

Despite being caught up in an explosive financial scandal that has dominated Brazil's election campaign, candidate Flavio Bolsonaro has gained ground with less than ...

Manhattan Associates (NASDAQ: MANH), the global leader in supply chain commerce with unmatched AI capabilities, today announced the commercial launch of ...

ELYDAN Group, specialist in water and energy network solutions, announces the acquisition of Radpol Pipes, a Polish industrial company specializing in the manufacture of pre-insulated piping systems ...

Vertex Pharmaceuticals Incorporated(Nasdaq: VRTX) today announced positive results from the Phase 2b AMPLIFIED study of inaxaplin in people with APOL1-mediated kidney disease (AMKD) and modest ...